Characteristic upregulation of dopamine D-1-receptor in rat striatum after 6-hydroxydopamine treatment

被引:10
作者
Iwata, S
Shimizu, T
Nomoto, M
Fukuda, T
机构
[1] Department of Pharmacology, Faculty of Medicine
关键词
H-3]SCH23390; 6-hydroxydopamine; upregulation;
D O I
10.1254/jjp.71.255
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We measured the number of D-1-receptors (B-max) in the striatum whose dopaminergic terminals were destroyed to various degrees by 6-hydroxydopamine (6-OHDA) to clarify the relationship between the degree of denervation and the change in B-max for D-1-receptor. Rats were sacrificed 28 days after 6-OHDA treatment, and [H-3]SCH23390 (R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine) binding capacity and monoamine content were measured in striatal homogenate. B-max was significantly upregulated when dopamine content was reduced to less than 5% of that in the vehicle-treated striatum. In contrast, it was significantly decreased when dopamine content was 5-25% of that in the vehicle-treated striatum. The D-1-receptors showed either upregulation or downregulation depending on the degree of denervation.
引用
收藏
页码:255 / 258
页数:4
相关论文
共 50 条
  • [41] RAPID AND LONG-LASTING REDUCTION OF THE HYPOTHERMIC EFFECT OF A D2 DOPAMINE AGONIST AFTER AN INTRACEREBROVENTRICULAR INJECTION OF 6-HYDROXYDOPAMINE
    SUAUDEAU, C
    DOURMAP, N
    COSTENTIN, J
    NEUROPHARMACOLOGY, 1995, 34 (01) : 101 - 105
  • [42] Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice
    Matsuura, K
    Kabuto, H
    Makino, H
    Ogawa, N
    NEUROSCIENCE LETTERS, 1997, 230 (03) : 191 - 194
  • [43] REGIONAL CHANGES OF STRIATAL DOPAMINE-RECEPTORS FOLLOWING DENERVATION BY 6-HYDROXYDOPAMINE AND FETAL MESENCEPHALIC GRAFTS IN THE RAT
    GAGNON, C
    BEDARD, PJ
    RIOUX, L
    GAUDIN, D
    MARTINOLI, MG
    PELLETIER, G
    DIPAOLO, T
    BRAIN RESEARCH, 1991, 558 (02) : 251 - 263
  • [44] ADRENAL-MEDULLARY ADAPTATIONS AND CARDIOVASCULAR REGULATION AFTER 6-HYDROXYDOPAMINE TREATMENT IN RATS
    KOLIBALPEGHER, S
    EDWARDS, DJ
    MEYERSSCHOY, SA
    VOLLMER, RR
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1994, 48 (02): : 113 - 120
  • [45] Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism
    Senthilkumar, Karuppagounder S.
    Saravanan, Karuppagounder S.
    Chandra, Goutam
    Sindhu, Kizhakke M.
    Jayakrishnan, A.
    Mohanakumar, Kochupurackal P.
    BEHAVIOURAL BRAIN RESEARCH, 2007, 184 (01) : 11 - 18
  • [46] STUDIES ON BRAIN MONOAMINE AND NEUROPEPTIDE SYSTEMS AFTER NEONATAL INTRACEREBROVENTRICULAR 6-HYDROXYDOPAMINE TREATMENT
    LUTHMAN, J
    BRODIN, E
    SUNDSTROM, E
    WIEHAGER, B
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1990, 8 (05) : 549 - 560
  • [47] Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-dopa treatment
    Medhurst, AD
    Zeng, BY
    Charles, KJ
    Gray, J
    Reavill, C
    Hunter, AJ
    Shale, JA
    Jenner, P
    NEUROSCIENCE, 2001, 105 (02) : 353 - 364
  • [48] POSTNATAL-DEVELOPMENT OF D1-DOPAMINE RECEPTORS IN THE MEDIAL PREFRONTAL CORTEX, STRIATUM AND NUCLEUS-ACCUMBENS OF NORMAL AND NEONATAL 6-HYDROXYDOPAMINE TREATED RATS - A QUANTITATIVE AUTORADIOGRAPHIC ANALYSIS
    LESLIE, CA
    ROBERTSON, MW
    CUTLER, AJ
    BENNETT, JP
    DEVELOPMENTAL BRAIN RESEARCH, 1991, 62 (01): : 109 - 114
  • [49] STIMULATION OF ADENYLATE-CYCLASE ACTIVITY BY BENZAZEPINE D-1 DOPAMINE AGONISTS WITH VARYING EFFICACIES IN THE 6-HYDROXYDOPAMINE LESIONED RAT-RELATIONSHIP TO CIRCLING BEHAVIOR
    GNANALINGHAM, KK
    HUNTER, AJ
    JENNER, P
    MARSDEN, CD
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (09) : 1185 - 1193
  • [50] PERSISTENCE OF LONG-LASTING SEROTONIN DEPLETION BY P-CHLOROAMPHETAMINE IN RAT-BRAIN AFTER 6-HYDROXYDOPAMINE LESIONING OF DOPAMINE NEURONS
    PERRY, KW
    KOSTRZEWA, RM
    FULLER, RW
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (08) : 1305 - 1307